Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.24.1.u1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Sep. 30, 2022 0 1,252,734      
Balance at Sep. 30, 2022 $ 0 $ 1,252 $ 50,878,718 $ (55,072,773) $ (4,192,803)
Net loss 0 0 0 (1,800,056) (1,800,056)
Stock-based compensation expense $ 0 $ 0 104,026 0 104,026
Balance (in shares) at Dec. 31, 2022 0 1,252,734      
Balance at Dec. 31, 2022 $ 0 $ 1,252 50,982,744 (56,872,829) (5,888,833)
Balance (in shares) at Sep. 30, 2022 0 1,252,734      
Balance at Sep. 30, 2022 $ 0 $ 1,252 50,878,718 (55,072,773) (4,192,803)
Net loss         (2,702,533)
Balance (in shares) at Mar. 31, 2023 0 1,274,601      
Balance at Mar. 31, 2023 $ 0 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Balance (in shares) at Dec. 31, 2022 0 1,252,734      
Balance at Dec. 31, 2022 $ 0 $ 1,252 50,982,744 (56,872,829) (5,888,833)
Net loss 0 0 0 (902,477) (902,477)
Stock-based compensation expense $ 0 $ 0 68,524 0 68,524
Balance (in shares) at Mar. 31, 2023 0 1,274,601      
Balance at Mar. 31, 2023 $ 0 $ 1,275 51,387,943 (57,775,306) (6,386,088)
Vesting of restricted stock (in shares) 0 250      
Vesting of restricted stock $ 0 $ 0 0 0 0
Issuance of common stock and warrants, net of financing costs (in shares) 0 9,598      
Issuance of common stock and warrants, net of financing costs $ 0 $ 10 287,410 0 287,420
Exchange of warrants into common stock (in shares) 0 12,019      
Exchange of warrants into common stock $ 0 $ 13 49,265 0 49,278
Balance (in shares) at Sep. 30, 2023 0 4,689,446      
Balance at Sep. 30, 2023 $ 0 $ 4,689 54,543,188 (62,055,609) (7,507,732)
Net loss $ 0 $ 0 0 (2,681,652) (2,681,652)
Issuance of common stock upon conversion of convertible notes, shares (in shares) 0 52,918      
Issuance of common stock upon conversion of convertible notes $ 0 $ 53 587,906 0 587,959
Stock-based compensation expense $ 0 $ 0 25,909 0 25,909
Balance (in shares) at Dec. 31, 2023 0 4,742,364      
Balance at Dec. 31, 2023 $ 0 $ 4,742 55,157,003 (64,737,261) (9,575,516)
Balance (in shares) at Sep. 30, 2023 0 4,689,446      
Balance at Sep. 30, 2023 $ 0 $ 4,689 54,543,188 (62,055,609) (7,507,732)
Net loss         (4,150,791)
Balance (in shares) at Mar. 31, 2024 0 4,444,364      
Balance at Mar. 31, 2024 $ 0 $ 4,444 55,324,472 (66,206,400) (10,877,484)
Balance (in shares) at Dec. 31, 2023 0 4,742,364      
Balance at Dec. 31, 2023 $ 0 $ 4,742 55,157,003 (64,737,261) (9,575,516)
Net loss $ 0 $ 0 0 (1,469,139) (1,469,139)
Issuance of common stock upon conversion of convertible notes, shares (in shares) 0 2,000      
Issuance of common stock upon conversion of convertible notes $ 0 $ 2 18,278 0 18,280
Issuance of warrants, net of financing costs 0 0 148,891 0 148,891
Exchange of common stock into warrants $ 0 $ (300) 300 0 0
Balance (in shares) at Mar. 31, 2024 0 4,444,364      
Balance at Mar. 31, 2024 $ 0 $ 4,444 $ 55,324,472 $ (66,206,400) $ (10,877,484)
Exchange of common stock into warrants, shares (in shares) 0 (300,000)